These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3986946)

  • 1. Susceptibility test methods which may be able to predict the emergence of resistance to newer beta- lactam antibiotics.
    Jorgensen JH
    Chemioterapia; 1985 Feb; 4(1):7-13. PubMed ID: 3986946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
    Dudley M
    Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of action of beta-lactam antibiotics and problems concerning the development of resistance in antibacterial chemotherapy].
    Semenitz E
    Wien Klin Wochenschr Suppl; 1983; 142():7-11. PubMed ID: 6606272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems with detection of beta-lactam resistance among nonfastidious gram-negative bacilli.
    Sanders CC; Thomson KS; Bradford PA
    Infect Dis Clin North Am; 1993 Jun; 7(2):411-24. PubMed ID: 8345176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of testing conditions on the susceptibility results of Staphylococcus cohnii to beta-lactams].
    Nowak T; Szewczyk EM
    Med Dosw Mikrobiol; 2006; 58(2):95-102. PubMed ID: 17133902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
    Kotra LP; Mobashery S
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of resistance to beta-lactam antibiotics.
    Wiedemann B; Tolxdorff-Neutzling RM
    Chemioterapia; 1985 Feb; 4(1):24-7. PubMed ID: 3986943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility testing of anaerobic bacteria.
    Sutter VL
    Am J Med Technol; 1976 Apr; 42(4):111-4. PubMed ID: 1266883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility testing: a review of general principles and contemporary practices.
    Jorgensen JH; Ferraro MJ
    Clin Infect Dis; 2009 Dec; 49(11):1749-55. PubMed ID: 19857164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.
    Anderson KF; Lonsway DR; Rasheed JK; Biddle J; Jensen B; McDougal LK; Carey RB; Thompson A; Stocker S; Limbago B; Patel JB
    J Clin Microbiol; 2007 Aug; 45(8):2723-5. PubMed ID: 17581941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion of beta-lactam antibiotics through oligomeric or monomeric porin channels of some gram-negative bacteria.
    Nitzan Y; Deutsch EB; Pechatnikov I
    Curr Microbiol; 2002 Dec; 45(6):446-55. PubMed ID: 12402087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guides for rational use of B-lactam antibiotics:resistance mechanism and clinical interpretation].
    Arias CA; Panesso D; Zúñiga M
    Biomedica; 2003 Jun; 23(2):134-40. PubMed ID: 12872552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of beta-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance.
    Athanassiou G; Michaleas S; Lada-Chitiroglou E; Tsitsa T; Antoniadou-Vyza E
    J Pharm Pharmacol; 2003 Mar; 55(3):291-300. PubMed ID: 12724033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaerobic bacteria and beta-lactam antibiotics.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 42():72-82. PubMed ID: 6335601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple method to determine beta-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test.
    Vedel G
    J Antimicrob Chemother; 2005 Oct; 56(4):657-64. PubMed ID: 16144872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility variation of 50 anaerobic periopathogens in aggressive periodontitis: an interindividual variability study.
    Lakhssassi N; Elhajoui N; Lodter JP; Pineill JL; Sixou M
    Oral Microbiol Immunol; 2005 Aug; 20(4):244-52. PubMed ID: 15943770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.